Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
T-Cell response to CD1-restricted lipids in Tuberculosis
Src family kinases and cell growth regulation
Episodic Hypoxia and Acute Cerebrovascular Inflammation
Software Development /Imb Computer Applications
National Epidermolysis Bullosa Registry Clinical Site
Recently added grants:
Social Processing Systems in Veterans with Schizophrenia: Identifying Deficits in Brain Activation and Network Organization
Brain Bioenergetic Response to Hypoxic Stress in Bipolar Disorder
Convergent Genetic and Genomic Analyses of Schizophrenia
Surgical Studies on the Role of MicroRNAs in Esophageal Cancer
Parenchymal and airway CD4+ T cells in protection against pulmonary tuberculosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-000
Application #
3609932
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant